1. The role of lipid droplets in metabolic disease in rodents and humans.
- Author
-
Greenberg AS, Coleman RA, Kraemer FB, McManaman JL, Obin MS, Puri V, Yan QW, Miyoshi H, and Mashek DG
- Subjects
- Adipocytes physiology, Adipocytes ultrastructure, Animals, Diabetes Mellitus physiopathology, Energy Metabolism physiology, Fatty Acids adverse effects, Fatty Acids metabolism, Fatty Liver physiopathology, Humans, Insulin Resistance, Intracellular Signaling Peptides and Proteins physiology, Lipolysis physiology, Mice, Mice, Mutant Strains, Muscle, Skeletal metabolism, Non-alcoholic Fatty Liver Disease, Obesity physiopathology, Signal Transduction physiology, Triglycerides metabolism, Adipose Tissue physiopathology, Lipids physiology, Metabolic Diseases physiopathology, Vacuoles physiology
- Abstract
Lipid droplets (LDs) are intracellular organelles that store neutral lipids within cells. Over the last two decades there has been a dramatic growth in our understanding of LD biology and, in parallel, our understanding of the role of LDs in health and disease. In its simplest form, the LD regulates the storage and hydrolysis of neutral lipids, including triacylglycerol and/or cholesterol esters. It is becoming increasingly evident that alterations in the regulation of LD physiology and metabolism influence the risk of developing metabolic diseases such as diabetes. In this review we provide an update on the role of LD-associated proteins and LDs in metabolic disease.
- Published
- 2011
- Full Text
- View/download PDF